Clinical Trial Using Bone Marrow-derived Mononuclear Cells for Spinal Cord Injury

NCT02923817 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injuries

Interventions

BIOLOGICAL: Transplantation of autologous bone marrow-derived mononuclear cells by lumbar injection

Sponsor

Da Nang Hospital

Collaborators

[object Object]
[object Object]